Stem Cell Patents Come Under Fire
By Associated Press,
Associated Press
| 07. 19. 2006
MILWAUKEE -- A consumer group, a patent foundation and a stem cell scientist are challenging patents on human embryonic stem cells held by the Wisconsin Alumni Research Foundation.
The Public Patent Foundation, the Foundation for Taxpayer and Consumer Rights, and Jeanne Loring, a stem cell scientist at the Burnham Institute for Medical Research in California, claim that the patents hinder research, push scientists to pursue work overseas and represent a waste of taxpayer money.
"It's absolutely absurd that one person or organization could own the rights to life itself," said John Simpson, stem cell project director of the Foundation for Taxpayer and Consumer Rights, based in California.
The Wisconsin Alumni Research Foundation _ or WARF _ is the patenting and licensing arm of the University of Wisconsin. University researcher Jamie Thomson first isolated embryonic stem cells in 1998.
WARF director Carl Gulbrandsen said he was confident the patents are valid, saying the challenge was motivated by politics and money.
"WARF stem cell patents do not inhibit research," he said. "They support and encourage it."
Simpson, Loring and others announced their...
Related Articles
It’s been a busy couple of months in biopolitics, with developments in the US, UK, China, Japan, and implicitly on Mars. Time for a brief roundup.
• • •
Bioethics needs an update
The National Research Act is now 50 years old. It was signed into law on July 12, 1974, as a direct response to publicity about the 1932 “Tuskegee Study of Untreated Syphilis in the Negro Male.” The Hastings Bioethics Forum celebrated its anniversary with an...
Image courtesy National Human Genome Research Institute
The U.S. Food and Drug Administration (FDA) is supposed to encourage effective medical advances while also ensuring that patients and research subjects are protected. This dual mandate demands tricky judgment calls that are made more difficult by outside pressures of several kinds, political, judicial, and especially commercial. This April story at Bloomberg examines one deeply troubling pattern of regulatory capture:
Americans Are Paying Billions to Take Drugs That Don’t Work
Companies are increasingly...
By Elizabeth Chuck, NBC News | 07.09.2024
A Netflix docuseries has put a spotlight on the unregulated world of sperm donation, particularly the lack of stopgap measures that might prevent donors who have been banned by one country from simply going elsewhere to donate more.
Released earlier...
By Amanda Becker and Shefali Luthra, The 19th | 07.08.2024
Image by Duke University Archives from Flickr
Republicans have adopted a slate of policy positions ahead of next week’s convention that does not call for a federal legislative abortion ban, but opens the door to establishing fetal personhood.
The Republican...